Tyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) patients was examined for the levels of
C-reactive protein, biomarker of systemic inflammation
of polymorphic variants of inflammation genes with MetS and serum levels of high-sensitivity
C-reactive protein dehydrogenase, and
C-reactive protein levels. Use of a model based on multivariate analysis allowed
DNA-binding
protein 43 kDa), tau, and FUS (fused in sarcoma)
proteins, which possess antiviral